FindTrial
Sign In

multi-center, Double-blind Randomized controlled trials of Chinese medicine to treatment myasthenia gravis patients

Clinical Evaluation of Chinese medicine to treat myasthenia gravis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12003062
Enrollment
Unknown
Registered
2012-04-19
Start date
2008-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia gravis

Interventions

treatment group:Western medicine and Chinese medicines granules
control group:Western medicine and Chinese medicines granules placebo

Sponsors

Guangzhou University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 70 Years

Inclusion criteria

Inclusion criteria: The patients with myasthenia gravis(II-B, III, IV type), those who aged between 10-70 years, and those who were diagnosed as the spleen and stomach Qi or spleen and kidney deficiency according to the traditional Chinese Medicine.

Exclusion criteria

Exclusion criteria: 1. combined malignant thymoma; 2. patients with severe diseases of other systems; 3. those receiving plasmapheresis treatment in the last three months; 4. those who are allergic to the drug.

Design outcomes

Primary

MeasureTime frame
myasthenia gravis absolute score;—

Secondary

MeasureTime frame
Myasthenic crisis incidence;Chinese Quality of Life Scale;myasthenia gravis quality of life scale;SF-36 scale;—

Countries

China

Contacts

Public ContactFengbin Liu
liufb163@163.com+86 18902296111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026